United States · FDA National Drug Code directory
PredniSONE Tablets, USP, 5 mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63561-0120_3c696af0-7946-dd78-e063-6394a90a71cc
- Product NDC
- 63561-0120
- Form
- TABLET
- Composition / generic term
- PredniSONE
- Labeler
- Granulation Technology, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250522
- Source listing expiry
- 20261231
Source-listed ingredients
- PREDNISONE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (63561-0120-1) · 63561-0120-1
- 1000 TABLET in 1 BOTTLE (63561-0120-2) · 63561-0120-2
- 500 TABLET in 1 BOTTLE (63561-0120-5) · 63561-0120-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →